Annual Revenue:
$2.88B+$549.90M(+23.63%)Summary
- As of March 31, 2025, UTHR annual revenue is $2.88 billion, with the most recent change of +$549.90 million (+23.63%) on December 31, 2024.
- During the last 3 years, UTHR annual revenue has risen by +$1.19 billion (+70.71%).
- UTHR annual revenue is now at all-time high.
Performance
UTHR Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue:
$735.90M-$13.00M(-1.74%)Summary
- As of March 31, 2025, UTHR quarterly revenue is $735.90 million, with the most recent change of -$13.00 million (-1.74%) on December 31, 2024.
- Over the past year, UTHR quarterly revenue has increased by +$121.20 million (+19.72%).
- UTHR quarterly revenue is now -1.74% below its all-time high of $748.90 million, reached on September 30, 2024.
Performance
UTHR Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Revenue:
$2.88B+$121.20M(+4.40%)Summary
- As of March 31, 2025, UTHR TTM revenue is $2.88 billion, with the most recent change of +$121.20 million (+4.40%) on December 31, 2024.
- Over the past year, UTHR TTM revenue has increased by +$549.90 million (+23.63%).
- UTHR TTM revenue is now at all-time high.
Performance
UTHR TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
UTHR Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +23.6% | +19.7% | +23.6% |
| 3 y3 years | +70.7% | +20.8% | +30.5% |
| 5 y5 years | +98.6% | +106.5% | +99.5% |
UTHR Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +70.7% | -1.7% | +77.2% | at high | +70.7% |
| 5 y | 5-year | at high | +98.6% | -1.7% | +136.6% | at high | +104.1% |
| alltime | all time | at high | >+9999.0% | -1.7% | >+9999.0% | at high | >+9999.0% |
United Therapeutics Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $2.88B(+23.6%) | $735.90M(-1.7%) | $2.88B(+4.4%) |
| Sep 2024 | - | $748.90M(+4.8%) | $2.76B(+5.3%) |
| Jun 2024 | - | $714.90M(+5.5%) | $2.62B(+4.7%) |
| Mar 2024 | - | $677.70M(+10.2%) | $2.50B(+7.3%) |
| Dec 2023 | $2.33B(+20.2%) | $614.70M(+0.9%) | $2.33B(+5.6%) |
| Sep 2023 | - | $609.40M(+2.2%) | $2.20B(+4.4%) |
| Jun 2023 | - | $596.50M(+17.7%) | $2.11B(+6.5%) |
| Mar 2023 | - | $506.90M(+3.1%) | $1.98B(+2.3%) |
| Dec 2022 | $1.94B(+14.9%) | $491.50M(-4.7%) | $1.94B(+4.1%) |
| Sep 2022 | - | $516.00M(+10.5%) | $1.86B(+4.0%) |
| Jun 2022 | - | $466.90M(+1.1%) | $1.79B(+1.2%) |
| Mar 2022 | - | $461.90M(+11.2%) | $1.77B(+4.9%) |
| Dec 2021 | $1.69B(+13.6%) | $415.20M(-6.6%) | $1.69B(+1.8%) |
| Sep 2021 | - | $444.70M(-0.4%) | $1.66B(+4.1%) |
| Jun 2021 | - | $446.50M(+17.8%) | $1.59B(+5.6%) |
| Mar 2021 | - | $379.10M(-1.5%) | $1.51B(+1.5%) |
| Dec 2020 | $1.48B(+2.4%) | $384.90M(+1.3%) | $1.48B(+5.2%) |
| Sep 2020 | - | $380.10M(+5.0%) | $1.41B(-1.5%) |
| Jun 2020 | - | $362.00M(+1.6%) | $1.43B(-0.8%) |
| Mar 2020 | - | $356.30M(+14.5%) | $1.44B(-0.4%) |
| Dec 2019 | $1.45B(-11.0%) | $311.10M(-22.5%) | $1.45B(-4.6%) |
| Sep 2019 | - | $401.50M(+7.5%) | $1.52B(-0.7%) |
| Jun 2019 | - | $373.60M(+3.0%) | $1.53B(-4.4%) |
| Mar 2019 | - | $362.60M(-4.9%) | $1.60B(-1.6%) |
| Dec 2018 | $1.63B(-5.7%) | $381.40M(-7.6%) | $1.63B(-4.9%) |
| Sep 2018 | - | $412.70M(-7.2%) | $1.71B(-1.9%) |
| Jun 2018 | - | $444.50M(+14.2%) | $1.74B(-0.0%) |
| Mar 2018 | - | $389.20M(-16.2%) | $1.74B(+1.1%) |
| Dec 2017 | $1.73B(+7.9%) | $464.70M(+4.3%) | $1.73B(+3.3%) |
| Sep 2017 | - | $445.50M(+0.2%) | $1.67B(+2.3%) |
| Jun 2017 | - | $444.60M(+20.0%) | $1.63B(+2.0%) |
| Mar 2017 | - | $370.50M(-9.4%) | $1.60B(+0.1%) |
| Dec 2016 | $1.60B(+9.1%) | $409.00M(+0.2%) | $1.60B(+0.3%) |
| Sep 2016 | - | $408.20M(-1.1%) | $1.59B(+1.4%) |
| Jun 2016 | - | $412.60M(+11.8%) | $1.57B(+4.3%) |
| Mar 2016 | - | $369.00M(-8.9%) | $1.51B(+2.8%) |
| Dec 2015 | $1.47B(+13.8%) | $404.90M(+4.8%) | $1.47B(+4.2%) |
| Sep 2015 | - | $386.20M(+11.2%) | $1.41B(+4.2%) |
| Jun 2015 | - | $347.20M(+6.0%) | $1.35B(+1.8%) |
| Mar 2015 | - | $327.50M(-5.4%) | $1.33B(+3.0%) |
| Dec 2014 | $1.29B(+15.4%) | $346.34M(+5.0%) | $1.29B(+4.7%) |
| Sep 2014 | - | $329.95M(+2.2%) | $1.23B(+2.3%) |
| Jun 2014 | - | $322.80M(+11.5%) | $1.20B(+3.6%) |
| Mar 2014 | - | $289.40M(+0.1%) | $1.16B(+4.0%) |
| Dec 2013 | $1.12B(+21.9%) | $289.02M(-4.4%) | $1.12B(+4.2%) |
| Sep 2013 | - | $302.23M(+7.7%) | $1.07B(+5.9%) |
| Jun 2013 | - | $280.61M(+14.5%) | $1.01B(+5.8%) |
| Mar 2013 | - | $245.14M(+0.5%) | $957.00M(+4.5%) |
| Dec 2012 | $916.08M(+23.3%) | $243.82M(+0.6%) | $916.08M(+5.6%) |
| Sep 2012 | - | $242.47M(+7.5%) | $867.44M(+4.9%) |
| Jun 2012 | - | $225.58M(+10.5%) | $826.71M(+5.3%) |
| Mar 2012 | - | $204.21M(+4.6%) | $784.88M(+5.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | $743.18M(+25.3%) | $195.18M(-3.3%) | $743.18M(+4.4%) |
| Sep 2011 | - | $201.74M(+9.8%) | $711.70M(+4.9%) |
| Jun 2011 | - | $183.75M(+13.1%) | $678.53M(+7.8%) |
| Mar 2011 | - | $162.51M(-0.7%) | $629.50M(+5.6%) |
| Dec 2010 | $592.90M(+60.3%) | $163.69M(-2.9%) | $595.87M(+10.1%) |
| Sep 2010 | - | $168.57M(+25.1%) | $541.10M(+15.2%) |
| Jun 2010 | - | $134.72M(+4.5%) | $469.74M(+12.1%) |
| Mar 2010 | - | $128.88M(+18.3%) | $419.00M(+13.3%) |
| Dec 2009 | $369.85M(+31.4%) | $108.92M(+12.0%) | $369.85M(+9.8%) |
| Sep 2009 | - | $97.22M(+15.8%) | $336.79M(+7.1%) |
| Jun 2009 | - | $83.98M(+5.3%) | $314.60M(+5.2%) |
| Mar 2009 | - | $79.73M(+5.1%) | $299.18M(+6.3%) |
| Dec 2008 | $281.50M(+33.4%) | $75.86M(+1.1%) | $281.50M(+6.0%) |
| Sep 2008 | - | $75.03M(+9.4%) | $265.53M(+6.4%) |
| Jun 2008 | - | $68.56M(+10.5%) | $249.55M(+7.2%) |
| Mar 2008 | - | $62.05M(+3.6%) | $232.82M(+10.4%) |
| Dec 2007 | $210.94M(+32.1%) | $59.90M(+1.4%) | $210.94M(+7.1%) |
| Sep 2007 | - | $59.05M(+13.9%) | $196.87M(+10.5%) |
| Jun 2007 | - | $51.83M(+29.0%) | $178.22M(+7.0%) |
| Mar 2007 | - | $40.17M(-12.3%) | $166.64M(+4.4%) |
| Dec 2006 | $159.63M(+37.7%) | $45.83M(+13.4%) | $159.63M(+11.3%) |
| Sep 2006 | - | $40.40M(+0.4%) | $143.45M(+5.4%) |
| Jun 2006 | - | $40.24M(+21.4%) | $136.06M(+8.1%) |
| Mar 2006 | - | $33.16M(+11.9%) | $125.87M(+8.6%) |
| Dec 2005 | $115.92M(+57.5%) | $29.64M(-10.2%) | $115.92M(+7.4%) |
| Sep 2005 | - | $33.01M(+9.8%) | $107.89M(+13.7%) |
| Jun 2005 | - | $30.06M(+29.5%) | $94.87M(+14.1%) |
| Mar 2005 | - | $23.21M(+7.4%) | $83.11M(+12.9%) |
| Dec 2004 | $73.59M(+38.0%) | $21.61M(+8.1%) | $73.59M(+12.2%) |
| Sep 2004 | - | $20.00M(+9.3%) | $65.57M(+8.2%) |
| Jun 2004 | - | $18.30M(+33.7%) | $60.61M(+7.7%) |
| Mar 2004 | - | $13.68M(+0.7%) | $56.28M(+5.5%) |
| Dec 2003 | $53.34M(+77.1%) | $13.59M(-9.6%) | $53.34M(+3.0%) |
| Sep 2003 | - | $15.04M(+7.6%) | $51.77M(+23.7%) |
| Jun 2003 | - | $13.98M(+30.2%) | $41.87M(+6.1%) |
| Mar 2003 | - | $10.74M(-10.7%) | $39.45M(+31.0%) |
| Dec 2002 | $30.12M(+425.5%) | $12.02M(+134.4%) | $30.12M(+52.8%) |
| Sep 2002 | - | $5.13M(-55.7%) | $19.72M(+24.0%) |
| Jun 2002 | - | $11.56M(+722.5%) | $15.91M(+181.2%) |
| Mar 2002 | - | $1.41M(-13.2%) | $5.66M(-1.3%) |
| Dec 2001 | $5.73M(+179.7%) | $1.62M(+23.1%) | $5.73M(+16.9%) |
| Sep 2001 | - | $1.32M(+0.1%) | $4.90M(+22.9%) |
| Jun 2001 | - | $1.31M(-11.4%) | $3.99M(+23.8%) |
| Mar 2001 | - | $1.48M(+87.7%) | $3.22M(+57.2%) |
| Dec 2000 | $2.05M(+369.5%) | $789.70K(+95.5%) | $2.05M(+37.0%) |
| Sep 2000 | - | $403.90K(-26.1%) | $1.50M(+25.5%) |
| Jun 2000 | - | $546.30K(+76.6%) | $1.19M(+59.8%) |
| Mar 2000 | - | $309.40K(+30.8%) | $745.90K(+39.0%) |
| Dec 1999 | $436.50K(+711.3%) | $236.50K(+136.5%) | $536.50K(+78.8%) |
| Sep 1999 | - | $100.00K(0.0%) | $300.00K(+50.0%) |
| Jun 1999 | - | $100.00K(0.0%) | $200.00K(+100.0%) |
| Mar 1999 | - | $100.00K | $100.00K |
| Dec 1998 | $53.80K | - | - |
FAQ
- What is United Therapeutics annual revenue?
- What is the all time high annual revenue for United Therapeutics?
- What is United Therapeutics annual revenue year-on-year change?
- What is United Therapeutics quarterly revenue?
- What is the all time high quarterly revenue for United Therapeutics?
- What is United Therapeutics quarterly revenue year-on-year change?
- What is United Therapeutics TTM revenue?
- What is the all time high TTM revenue for United Therapeutics?
- What is United Therapeutics TTM revenue year-on-year change?
What is United Therapeutics annual revenue?
The current annual revenue of UTHR is $2.88B
What is the all time high annual revenue for United Therapeutics?
United Therapeutics all-time high annual revenue is $2.88B
What is United Therapeutics annual revenue year-on-year change?
Over the past year, UTHR annual revenue has changed by +$549.90M (+23.63%)
What is United Therapeutics quarterly revenue?
The current quarterly revenue of UTHR is $735.90M
What is the all time high quarterly revenue for United Therapeutics?
United Therapeutics all-time high quarterly revenue is $748.90M
What is United Therapeutics quarterly revenue year-on-year change?
Over the past year, UTHR quarterly revenue has changed by +$121.20M (+19.72%)
What is United Therapeutics TTM revenue?
The current TTM revenue of UTHR is $2.88B
What is the all time high TTM revenue for United Therapeutics?
United Therapeutics all-time high TTM revenue is $2.88B
What is United Therapeutics TTM revenue year-on-year change?
Over the past year, UTHR TTM revenue has changed by +$549.90M (+23.63%)